CA2342072A1 - Polypeptide zkun6 du domaine de kunitz - Google Patents
Polypeptide zkun6 du domaine de kunitz Download PDFInfo
- Publication number
- CA2342072A1 CA2342072A1 CA002342072A CA2342072A CA2342072A1 CA 2342072 A1 CA2342072 A1 CA 2342072A1 CA 002342072 A CA002342072 A CA 002342072A CA 2342072 A CA2342072 A CA 2342072A CA 2342072 A1 CA2342072 A1 CA 2342072A1
- Authority
- CA
- Canada
- Prior art keywords
- kunitz domain
- zkun6
- domain polypeptide
- proteinase inhibitors
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14809298A | 1998-09-03 | 1998-09-03 | |
US09/148,092 | 1998-09-03 | ||
PCT/US1999/020202 WO2000014235A1 (fr) | 1998-09-03 | 1999-09-01 | Polypeptide zkun6 du domaine de kunitz |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2342072A1 true CA2342072A1 (fr) | 2000-03-16 |
CA2342072C CA2342072C (fr) | 2005-01-11 |
Family
ID=22524234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002342072A Expired - Fee Related CA2342072C (fr) | 1998-09-03 | 1999-09-01 | Polypeptide zkun6 du domaine de kunitz |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1108029A1 (fr) |
JP (1) | JP2002524076A (fr) |
AU (1) | AU5805499A (fr) |
CA (1) | CA2342072C (fr) |
IL (1) | IL141644A0 (fr) |
WO (1) | WO2000014235A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
PT2311432E (pt) | 2002-06-07 | 2015-02-09 | Dyax Corp | Polipeptídeos de domínio kunitz modificado e sua utilização para a redução de isquemia ou aparecimento de uma resposta inflamatória sistémica associada a um procedimento cirúrgico |
AU2012216529B2 (en) * | 2002-08-28 | 2014-12-11 | Takeda Pharmaceutical Company Limited | Methods for preserving organs and tissues |
DK1542710T3 (da) * | 2002-08-28 | 2012-10-15 | Dyax Corp | Fremgangsmåde til konservering af organer og væv |
US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
JPWO2009101737A1 (ja) * | 2008-02-14 | 2011-06-02 | 国立大学法人大阪大学 | メチオニン残基含有ペプチドタグ付きタンパク質発現ベクター |
AU2010203712A1 (en) | 2009-01-06 | 2010-07-15 | Dyax Corp. | Treatment of mucositis with kallikrein inhibitors |
LT2521568T (lt) | 2010-01-06 | 2018-12-10 | Dyax Corp. | Plazmos kalikreiną surišantys baltymai |
CN105713092B (zh) | 2011-01-06 | 2019-09-10 | 戴埃克斯有限公司 | 血浆前激肽释放酶结合蛋白 |
AU2016366557B2 (en) | 2015-12-11 | 2024-01-25 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE529444T1 (de) * | 1994-01-11 | 2011-11-15 | Dyax Corp | Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten |
-
1999
- 1999-09-01 EP EP99945458A patent/EP1108029A1/fr not_active Withdrawn
- 1999-09-01 IL IL14164499A patent/IL141644A0/xx unknown
- 1999-09-01 CA CA002342072A patent/CA2342072C/fr not_active Expired - Fee Related
- 1999-09-01 JP JP2000568978A patent/JP2002524076A/ja active Pending
- 1999-09-01 WO PCT/US1999/020202 patent/WO2000014235A1/fr not_active Application Discontinuation
- 1999-09-01 AU AU58054/99A patent/AU5805499A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1108029A1 (fr) | 2001-06-20 |
IL141644A0 (en) | 2002-03-10 |
AU5805499A (en) | 2000-03-27 |
JP2002524076A (ja) | 2002-08-06 |
WO2000014235A1 (fr) | 2000-03-16 |
CA2342072C (fr) | 2005-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2263889A1 (fr) | Proteines ligands de p-selectine | |
EP0994190A3 (fr) | Séquence d'ADN conferant aux bactéries une résistance à l'homosérine et son utilisation | |
WO1998051799A1 (fr) | Nouvel inhibiteur de differentiation | |
BG102554A (en) | Vectors and methods for gene transfer into cells | |
DE69133587D1 (de) | Rekombinante DNS-Sequenzen kodierend für Enzyme frei von Feedback-Inhibition, Plasmide, die diese Sequenzen enthalten, transformierte Mikroorganismen, nützlich für Produktion aromatischer Aminosäuren, und deren Verfahren zur Herstellung durch Fermentation | |
CA2079229A1 (fr) | Protease specifique de l'ubiquitine | |
CA2342072A1 (fr) | Polypeptide zkun6 du domaine de kunitz | |
WO2000034474A3 (fr) | Zvegf3 homologue du facteur de croissance | |
ATE282705T1 (de) | Verbessertes barstar-gen | |
EP1137808A4 (fr) | Methodes de fabrication de cellules recombinees | |
Stepanov et al. | Intracellular serine protease from Bacillus subtilis. Structural comparison with extracellular serine proteases-subtilisins | |
CA2260365A1 (fr) | Polypeptide de differenciation-suppressive | |
Kim et al. | Molecular cloning and nucleotide sequence of Streptomyces griseus trypsin gene | |
NZ506748A (en) | Nucleic acids encoding a GFR alpha 3 polypeptide; host cell and vectors for production of the GRF alpha 3 protein and an assay for detecting GRFalpha 3 production | |
WO2002030958A3 (fr) | Fragment peptidique de caseine presentant une activite influant sur la croissance de cultures cellulaires | |
WO2001064888A3 (fr) | Polypeptide zkun8 a domaine kunitz | |
DE69633676D1 (de) | Alkaline protease, verfahren zu ihrer herstellung, anwendung derselben und diese herstellende mikroorganismen | |
Schlatter et al. | The primary structure of the psychrophilic lactate dehydrogenase from Bacillus psychrosaccharolyticus | |
EP2281892A3 (fr) | Procédé de préparer des polypeptides dans de cellules Trichoderma avec des déficiences respiratoires | |
US4935351A (en) | Process for preparing oligopeptide | |
WO2002010384A1 (fr) | Genes codant des proteines capables de regenerer la luciferine, adn recombine et methode de production de proteines capables de regenerer la luciferine | |
AU6659896A (en) | Protein with plant protecting properties | |
Tobe et al. | Purification and some properties of alkaline proteinase from Bacillus sp. | |
DE69941789D1 (de) | In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten | |
WO2001047958A3 (fr) | Polypeptide zkun10 du domaine de kunitz |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |